Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
RESEARCH TOOLSreports
Rani Therapeutics Holdings (RANI) Stock Price & Analysis
157 Followers
RANI Stock Chart & Stats
Day’s Range$5.75 - $6.42
52-Week Range― - ―
Previous Close$5.76
Volume199.92K
Average Volume (3M)N/A
Market Cap
$310.97M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 08, 2024EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.20Price Target Upside48.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Rani Therapeutics Holdings News
PremiumCompany Announcements
Rani Therapeutics Reports Positive Phase 1 Trial Outcomes
PremiumCompany Announcements
Rani Therapeutics Shares Exciting Clinical Trial ResultsRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
The estimated number of people who visited one or more of the websites owned by Rani Therapeutics Holdings
Desktop Users
Mobile Users
RANI FAQ
What was Rani Therapeutics Holdings’s price range in the past 12 months?
Currently, no data Available
What is Rani Therapeutics Holdings’s market cap?
Currently, no data Available
When is Rani Therapeutics Holdings’s upcoming earnings report date?
Rani Therapeutics Holdings’s upcoming earnings report date is May 08, 2024 which is in 20 days.
How were Rani Therapeutics Holdings’s earnings last quarter?
Rani Therapeutics Holdings released its earnings results on Mar 20, 2024. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.38 by $0.11.
Is Rani Therapeutics Holdings overvalued?
According to Wall Street analysts Rani Therapeutics Holdings’s price is currently Undervalued.
Does Rani Therapeutics Holdings pay dividends?
Rani Therapeutics Holdings does not currently pay dividends.
What is Rani Therapeutics Holdings’s EPS estimate?
Rani Therapeutics Holdings’s EPS estimate is -$0.28.
How many shares outstanding does Rani Therapeutics Holdings have?
Currently, no data Available
What happened to Rani Therapeutics Holdings’s price movement after its last earnings report?
Rani Therapeutics Holdings reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.38. Following the earnings report the stock price went up 0.84%.
Which hedge fund is a major shareholder of Rani Therapeutics Holdings?
Currently, no hedge funds are holding shares in RANI
---
Rani Therapeutics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.20 (48.39% Upside)
$9.20 (48.39% Upside)
Blogger Sentiment
Bullish
RANI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.92%
12-Months-Change
Fundamentals
Return on Equity
-136.64%
Trailing 12-Months
Asset Growth
-46.39%
Trailing 12-Months
Company Description
Rani Therapeutics Holdings
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
---
RANI Earnings Call
Q4 2024
0:00 / 0:00
---
RANI Stock 12 Months Forecast
Average Price Target
$9.20
▲(48.39% Upside)
Technical Analysis
Best Analysts Covering RANI
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
+14.22%
reiterated a buy rating 25 days ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +14.22% per trade.
---